Proteomics in discovery of hepatocellular carcinoma biomarkers

被引：0
|
作者：
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构：
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2007年 / 19卷 / 03期
关键词：
proteomics; biomarker; hepatocellular carcinoma;
D O I：
10.1007/s11670-007-0159-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码：159 / 164
页数：6
相关论文
共 50 条
  • [41] Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry
    Mun, Sora
    Lee, Jiyeong
    Park, Arum
    Kim, Hyo-Jin
    Lee, Yoo-Jin
    Son, Hyunsong
    Shin, Miji
    Lim, Mi-Kyoung
    Kang, Hee-Gyoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [42] Predictive biomarkers for systemic therapy of hepatocellular carcinoma
    Moldogazieva, Nurbubu T.
    Zavadskiy, Sergey P.
    Sologova, Susanna S.
    Mokhosoev, Innokenty M.
    Terentiev, Alexander A.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021, 21 (11) : 1147 - 1164
  • [43] Clinical utility of serum biomarkers for hepatocellular carcinoma
    Xu, Xin-Fei
    Liang, Lei
    Xing, Hao
    Shen, Feng
    Huang, Dong-Sheng
    Lau, Wan Yee
    Yang, Tian
    BIOMARKERS IN MEDICINE, 2021, 15 (03) : 151 - 155
  • [44] Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
    Mu, Hong
    Lin, Kai-Xuan
    Zhao, Hong
    Xing, Shu
    Li, Cong
    Liu, Fang
    Lu, Hai-Zhen
    Zhang, Ze
    Sun, Yu-Lin
    Yan, Xi-Yun
    Cai, Jian-Qiang
    Zhao, Xiao-Hang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (19) : 5826 - 5838
  • [45] Emerging evidence of molecular biomarkers in hepatocellular carcinoma
    Umeda, Shinichi
    Kanda, Mitsuro
    Kodera, Yasuhiro
    HISTOLOGY AND HISTOPATHOLOGY, 2018, 33 (04) : 343 - 355
  • [46] Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
    Hong Mu
    Kai-Xuan Lin
    Hong Zhao
    Shu Xing
    Cong Li
    Fang Liu
    Hai-Zhen Lu
    Ze Zhang
    Yu-Lin Sun
    Xi-Yun Yan
    Jian-Qiang Cai
    Xiao-Hang Zhao
    World Journal of Gastroenterology, 2014, 20 (19) : 5826 - 5838
  • [47] Hepatocellular carcinoma: Review of disease and tumor biomarkers
    Jin Un Kim
    Mohamed I F Shariff
    Mary M E Crossey
    Maria Gomez-Romero
    Elaine Holmes
    I Jane Cox
    Haddy K S Fye
    Ramou Njie
    Simon D Taylor-Robinson
    World Journal of Hepatology, 2016, (10) : 471 - 484
  • [48] Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma
    Kim, Kwang Hoe
    Kim, Jin Young
    Yoo, Jong Shin
    EXPERT REVIEW OF PROTEOMICS, 2019, 16 (07) : 553 - 568
  • [49] Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
    Peng, Xuenan
    Gong, Caifeng
    Zhang, Wen
    Zhou, Aiping
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [50] MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
    Hayes, C. Nelson
    Chayama, Kazuaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03)
12345